Back to Journals Clinical Ophthalmology Volume 19 GLP-1R Agonists Improve Ocular Surface Parameters in Type 2 Diabetes Mellitus Authors Ottonelli G, Gaeta A , Montericcio N , Tredici C, Ortfeldt V, Birtolo MF , Jaafar S , Mirani M , Di Maria A Received 17 June 2025 Accepted for publication 14 September 2025 Published 15 October 2025 Volume 2025:19 Pages 38293836 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Scott Fraser Giovanni Ottonelli, 1 Alessandro Gaeta, 2 Novella Montericcio, 3 Costanza Tredici, 1 Vittoria Ortfeldt, 4 Maria Francesca Birtolo, 4, 5 Simona Jaafar, 4, 5 Marco Mirani, 5 Alessandra Di Maria 1 1 Department of Ophthalmology, IRCCS Humanitas Research Hospital, Milan, 20089, Italy
And it cant be done, and it is being done
If additional glycemic control is needed, increase the dose to 1.2 mg daily, and if additional glycemic control is still required, increase to 1.8 mg daily after at least 1 week of treatment with the 1.2 mg daily dose
Bacteriostatic Water is manufactured to Water for Injection USP standards, requiring production by distillation or reverse osmosis from a suitable water source, testing for bacterial endotoxins below 0.25 EU/mL by the LAL method, sterility testing by membrane filtration to confirmed absence of microbial contamination, particulate matter testing below USP limits, pH within the 4.57.0 range, and osmolality confirmation consistent with a non-electrolyte aqueous solution